Blair William & CO Rocket Pharmaceuticals, Inc. Call Options Transaction History
Blair William & CO
- $31.4 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$353 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$183 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$107 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$83.7 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.51B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...